Quantitative ligandomics for systematic identification of therapeutic ligands
The present invention is directed to methods for systematic identification of cellular ligands, disease-associated ligands, age-related ligands and receptor-specific ligands. Disease-associated ligands are promising targets to develop novel ligand-based therapies. The methods are broadly applicable to any type of cells or diseases in in vitro and in vivo settings. This invention further used the methods to identify Scg3 as a disease-related angiogenic factor for the therapy of diabetic retinopathy, diabetic macular edema, proliferative diabetic retinopathy, vascular age-related macular degeneration, diabetic foot and cancers.
G C C A C C C C G
G01N C07K C07K A61K C40B C07K C12N C07K G01N
inventional inventional inventional additional additional additional inventional additional additional
Wei
Li